Introduction Chronic pain and breakthrough cancer pain (BTcP) have a high prevalence in
all cancer types and cancer stages, combined with a significant physical, psychological, and …

Introduction Breakthrough pain (BP) is a complex phenomenon that has been reported to
have a relevant role in the global management of cancer pain. Radiotherapy (RT) has a …

Introduction This study aimed to assess the percentage of patients treated according to the
European Society for Medical Oncology (ESMO) 2018 guidelines for breakthrough cancer …

Background: The aim of this study was to identify potential variables influencing the clinical
presentation of breakthrough cancer pain (BTP). Methods: Cancer patients with a diagnosis …

Cancer pain requires careful comprehensive patient evaluation and an appropriate and
personalized clinical approach by a trained multidisciplinary team. The proper assessment …

Purpose. This study aimed to characterize breakthrough pain (BTP) and investigate its
impact on quality-of-life (QoL) in terminally-ill cancer patients. Similarities and differences …

Background This study aimed to assess the characteristics of breakthrough cancer pain
(BTcP) in patients receiving low doses of opioids for background pain in comparison with …

ABSTRACT Introduction: Breakthrough cancer pain (BTcP) is an episode of severe intensity
in patients receiving an adequate treatment with opioids able to provide at least mild …

Abstract Background: Breakthrough cancer pain (BTcP) is a predictor of interference with
general activities and poor pain management. The extent of this influence has not yet been …

Background Cancer pain is one of the most important symptoms for patients.
Pharmacological control is central for clinical management and to ensure well-being. In …